280 related articles for article (PubMed ID: 24789684)
1. Unexpected targets and triggers of autoimmunity.
Lee Y; Collins M; Kuchroo VK
J Clin Immunol; 2014 Jul; 34 Suppl 1(0 1):S56-60. PubMed ID: 24789684
[TBL] [Abstract][Full Text] [Related]
2. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
[TBL] [Abstract][Full Text] [Related]
3. Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity.
Burkett PR; Meyer zu Horste G; Kuchroo VK
J Clin Invest; 2015 Jun; 125(6):2211-9. PubMed ID: 25961452
[TBL] [Abstract][Full Text] [Related]
4. Th17 cells in inflammation and autoimmunity.
Singh RP; Hasan S; Sharma S; Nagra S; Yamaguchi DT; Wong DT; Hahn BH; Hossain A
Autoimmun Rev; 2014 Dec; 13(12):1174-81. PubMed ID: 25151974
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1β-Producing Myeloid Cells that Promote Pathogenic T Cells.
McGinley AM; Sutton CE; Edwards SC; Leane CM; DeCourcey J; Teijeiro A; Hamilton JA; Boon L; Djouder N; Mills KHG
Immunity; 2020 Feb; 52(2):342-356.e6. PubMed ID: 32023490
[TBL] [Abstract][Full Text] [Related]
6. Interplay among cytokines and T cell subsets in the progression and control of immune-mediated diseases.
Moudgil KD
Cytokine; 2015 Jul; 74(1):1-4. PubMed ID: 26026376
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis.
Astry B; Venkatesha SH; Moudgil KD
Cytokine; 2015 Jul; 74(1):54-61. PubMed ID: 25595306
[TBL] [Abstract][Full Text] [Related]
8. Are Th17 cells in the gut pathogenic or protective?
Symons A; Budelsky AL; Towne JE
Mucosal Immunol; 2012 Jan; 5(1):4-6. PubMed ID: 22071661
[TBL] [Abstract][Full Text] [Related]
9. IL-23: one cytokine in control of autoimmunity.
Croxford AL; Mair F; Becher B
Eur J Immunol; 2012 Sep; 42(9):2263-73. PubMed ID: 22949325
[TBL] [Abstract][Full Text] [Related]
10. The pathogenicity of Th17 cells in autoimmune diseases.
Yasuda K; Takeuchi Y; Hirota K
Semin Immunopathol; 2019 May; 41(3):283-297. PubMed ID: 30891627
[TBL] [Abstract][Full Text] [Related]
11. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.
Stadhouders R; Lubberts E; Hendriks RW
J Autoimmun; 2018 Feb; 87():1-15. PubMed ID: 29275836
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic benefits of regulating inflammation in autoimmunity.
Nikoopour E; Schwartz JA; Singh B
Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
[TBL] [Abstract][Full Text] [Related]
13. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.
Kikly K; Liu L; Na S; Sedgwick JD
Curr Opin Immunol; 2006 Dec; 18(6):670-5. PubMed ID: 17010592
[TBL] [Abstract][Full Text] [Related]
14. Targeting IL-17 in autoimmunity and inflammation.
Kim BS; Park YJ; Chung Y
Arch Pharm Res; 2016 Nov; 39(11):1537-1547. PubMed ID: 27576555
[TBL] [Abstract][Full Text] [Related]
15. MCAM-expressing CD4(+) T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases.
Dagur PK; Biancotto A; Wei L; Sen HN; Yao M; Strober W; Nussenblatt RB; McCoy JP
J Autoimmun; 2011 Dec; 37(4):319-27. PubMed ID: 21959269
[TBL] [Abstract][Full Text] [Related]
16. Role of Th1 and Th17 cells in organ-specific autoimmunity.
Dardalhon V; Korn T; Kuchroo VK; Anderson AC
J Autoimmun; 2008 Nov; 31(3):252-6. PubMed ID: 18502610
[TBL] [Abstract][Full Text] [Related]
17. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
Yamagata T; Skepner J; Yang J
Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
[TBL] [Abstract][Full Text] [Related]
18. A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders.
Kamali AN; Noorbakhsh SM; Hamedifar H; Jadidi-Niaragh F; Yazdani R; Bautista JM; Azizi G
Mol Immunol; 2019 Jan; 105():107-115. PubMed ID: 30502718
[TBL] [Abstract][Full Text] [Related]
19. The IL-17 pathway as a major therapeutic target in autoimmune diseases.
Hu Y; Shen F; Crellin NK; Ouyang W
Ann N Y Acad Sci; 2011 Jan; 1217():60-76. PubMed ID: 21155836
[TBL] [Abstract][Full Text] [Related]
20. Induction and molecular signature of pathogenic TH17 cells.
Lee Y; Awasthi A; Yosef N; Quintana FJ; Xiao S; Peters A; Wu C; Kleinewietfeld M; Kunder S; Hafler DA; Sobel RA; Regev A; Kuchroo VK
Nat Immunol; 2012 Oct; 13(10):991-9. PubMed ID: 22961052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
